$2.3M
The pre-seed round will fund clinical research and regulatory approval for the company's neurostimulation headband.
SN
Samphire Neuroscience
Medical technology company developing wearable solutions for women's health.
London, UK—Founded 2021
$2.3MTotal raised
Samphire Neuroscience is a medical technology company developing a neurotechnology wearable designed to manage menstrual pain and premenstrual syndrome.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Current assets
Members only
Cash, assets and headcount from Samphire Neuroscience's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
ER
Emilė Radytė
CEO and Co-Founder
Emilė is co-founder and CEO of Samphire Neuroscience. She previously co-directed the Integrative Neuroscience Association.
LinkedIn
Alex Cook
Co-Founder
Alex co-founded Samphire Neuroscience, following roles including venture fellow at AfterWork Ventures and hardware prototyping commercialisation at HAX. Earlier experience includes intellectual property and technology law at Herbert Smith Freehills and commercial and product work at Bamboo.
LinkedIn